Here you go!

"The effects seen in the BETonMACE trial for those with cognitive impairment are very promising and suggest that epigenetic modulators such as apabetalone may represent an important and novel approach to treatment of cognitive disorders,” stated Dr. Jeff Cummings, Vice Chair of Lou Ruvo Brain Health Center, Las Vegas, and one of the presenters during the CtAD Symposium.

Koo